The Resource FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997

FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997

Label
FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997
Title
FDA oversight
Title remainder
blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997
Title variation
Federal Drug Administration oversight
Creator
Author
Subject
Language
eng
Cataloging source
OCLCE
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://bibfra.me/vocab/lite/organizationName
United States
http://library.link/vocab/subjectName
  • Plasma products
  • Blood plasma
  • Blood
Label
FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997
Instantiates
Publication
Note
  • Title from title screen (viewed on Oct. 5, 2015)
  • "Serial no. 105-70."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
unknown
Extent
1 online resource (iii, 427 pages)
File format
one file format
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations
Specific material designation
remote
Label
FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997
Publication
Note
  • Title from title screen (viewed on Oct. 5, 2015)
  • "Serial no. 105-70."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
unknown
Extent
1 online resource (iii, 427 pages)
File format
one file format
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations
Specific material designation
remote

Library Locations

    • Biddle Law LibraryBorrow it
      3400 Chestnut Street, Philadelphia, Pennsylvania, 19104, US
      39.954941 -75.193362
Processing Feedback ...